BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 10665265)

  • 1. Neuropsychiatry of Huntington's disease and other basal ganglia disorders.
    Rosenblatt A; Leroi I
    Psychosomatics; 2000; 41(1):24-30. PubMed ID: 10665265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY).
    van Duijn E; Craufurd D; Hubers AA; Giltay EJ; Bonelli R; Rickards H; Anderson KE; van Walsem MR; van der Mast RC; Orth M; Landwehrmeyer GB;
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1411-8. PubMed ID: 24828898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatry of Huntington's disease.
    Rosenblatt A
    Dialogues Clin Neurosci; 2007; 9(2):191-7. PubMed ID: 17726917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of psychiatric symptoms in Huntington's disease.
    Anderson KE; Marder KS
    Curr Psychiatry Rep; 2001 Oct; 3(5):379-88. PubMed ID: 11559474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural problems in Huntington's disease using the Problem Behaviours Assessment.
    Kingma EM; van Duijn E; Timman R; van der Mast RC; Roos RA
    Gen Hosp Psychiatry; 2008; 30(2):155-61. PubMed ID: 18291297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopathology in verified Huntington's disease gene carriers.
    van Duijn E; Kingma EM; van der Mast RC
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):441-8. PubMed ID: 18070848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association.
    Lauterbach EC; Cummings JL; Duffy J; Coffey CE; Kaufer D; Lovell M; Malloy P; Reeve A; Royall DR; Rummans TA; Salloway SP
    J Neuropsychiatry Clin Neurosci; 1998; 10(3):249-66. PubMed ID: 9706533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Idiopathic bilateral basal ganglia calcification (Fahr's disease) presenting with psychotic depression and criminal violence: a case report with forensic aspect].
    Özer Ü; Görgülü Y; Can Güngör F; Gençtürk M
    Turk Psikiyatri Derg; 2014; 25(2):140-4. PubMed ID: 24936761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: the IMAGE-HD study.
    Gray MA; Egan GF; Ando A; Churchyard A; Chua P; Stout JC; Georgiou-Karistianis N
    Exp Neurol; 2013 Jan; 239():218-28. PubMed ID: 23123406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Course of irritability, depression and apathy in Huntington's disease in relation to motor symptoms during a two-year follow-up period.
    van Duijn E; Reedeker N; Giltay EJ; Eindhoven D; Roos RA; van der Mast RC
    Neurodegener Dis; 2014; 13(1):9-16. PubMed ID: 23948661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is Huntington's disease a neurological or psychiatric disorder? case report].
    Dubas-Slemp H; Tylec A; Michałowska-Marmurowska H; Spychalska K
    Psychiatr Pol; 2012; 46(5):915-22. PubMed ID: 23394029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric complications of some basal-ganglia disorders.
    Whitlock FA
    Br J Hosp Med; 1988 Nov; 40(5):391, 394-5. PubMed ID: 3069174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease.
    Leroi I; O'Hearn E; Marsh L; Lyketsos CG; Rosenblatt A; Ross CA; Brandt J; Margolis RL
    Am J Psychiatry; 2002 Aug; 159(8):1306-14. PubMed ID: 12153822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropsychiatry of neuroacanthocytosis syndromes.
    Walterfang M; Evans A; Looi JC; Jung HH; Danek A; Walker RH; Velakoulis D
    Neurosci Biobehav Rev; 2011 Apr; 35(5):1275-83. PubMed ID: 21237198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease.
    Thompson JC; Harris J; Sollom AC; Stopford CL; Howard E; Snowden JS; Craufurd D
    J Neuropsychiatry Clin Neurosci; 2012; 24(1):53-60. PubMed ID: 22450614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute psychosis in a verified Huntington disease gene carrier with subtle motor signs: psychiatric criteria should be considered for the diagnosis.
    Nagel M; Rumpf HJ; Kasten M
    Gen Hosp Psychiatry; 2014; 36(3):361.e3-4. PubMed ID: 24576988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of the psychiatric manifestations of Huntington's disease: a review of the literature.
    Leroi I; Michalon M
    Can J Psychiatry; 1998 Nov; 43(9):933-40. PubMed ID: 9825166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropsychiatry Of Movement Disorders].
    Orjuela-Rojas JM; Barrios Vincos GA; Martínez Gallego MA
    Rev Colomb Psiquiatr; 2017 Oct; 46 Suppl 1():59-68. PubMed ID: 29037340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-Motor Phenotype Relates to Neuropsychiatric and Cognitive Disorders in Huntington's Disease.
    Julayanont P; Heilman KM; McFarland NR
    Mov Disord; 2020 May; 35(5):781-788. PubMed ID: 31922295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.